Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesiritide in Resistant Hypertension
NCT01514357Phase 2Terminated
- Start
- Apr 2012
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of nesiritide in resistant hypertension (RH). Started Apr 2012; status: terminated.
02
Drugs
nesiritide
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT01514357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01514357.